What is the price of Impact BioMedical Inc. (IBO)

The price of Impact BioMedical Inc. (IBO) is $0.4587

What is the market cap of Impact BioMedical Inc. (IBO)

The market cap of Impact BioMedical Inc. (IBO) is $49.46M

Impact BioMedical Inc. (IBO) Dividends

Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.

Year	Dividend (stock split adjusted)	Change
Not enough data for the provided dates.

Year

Dividend (stock split adjusted)

Change

Not enough data for the provided dates.

Year	Dividend	Change
Not enough data for the provided dates.

Year

Dividend

Change

Not enough data for the provided dates.

Company	Number of dividend payments	Country
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
CSL Limited CSL.AX	64.00%	AU
Lonza Group AG LONN.SW	0.00%	CH
Moderna, Inc. MRNA.US	0.00%	US

Company

Number of dividend payments

Country